This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biolase Inc (BIOL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 31.56M 1.44M 2.54M 3.31M
Receivables 9.00M 11.13M 11.68M 8.90M
Inventories 12.51M 11.38M 11.14M 11.31M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 54.80M 25.85M 26.92M 25.33M
Property, Plant & Equipment, Gross 6.96M 8.80M 8.03M 8.31M
Accumulated Depreciation & Depletion 5.67M 6.97M 6.52M 7.16M
Property, Plant & Equipment, Net 1.30M 1.83M 1.51M 1.15M
Intangibles 114.00K 183.00K 300.00K 212.00K
Other Non-Current Assets 270.00K 249.00K 305.00K 187.00K
Total Non-Current Assets 4.60M 5.18M 5.06M 4.48M
Liabilities & Shareholder Equity
Total Assets 59.40M 31.04M 31.97M 29.81M
Accounts Payable 8.36M 8.56M 7.66M 7.80M
Short Term Debt 0.00 4.63M 1.64M 0.00
Other Current Liabilities 139.00K 0.00 4.57M 165.00K
Total Current Liabilities 16.15M 21.94M 19.38M 16.28M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 677.00K 617.00K 663.00K 594.00K
Other Non-Current Liabilities 519.00K 1.00K 141.00K 362.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.20M 618.00K 804.00K 956.00K
Total Liabilities 17.35M 22.56M 20.18M 17.24M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 42.06M 8.48M 11.79M 12.57M
Common Par 58.00K 38.00K 34.00K 33.00K
Additional Paid In Capital 185.23M 148.87M 140.75M 138.51M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -142.68M -123.75M -112.27M -109.21M
Treasury Stock 0.00 -16.40M -16.40M -16.40M
Other Equity Adjustments -557.00K -274.00K -320.00K -360.00K
Total Capitalization 42.06M 8.48M 11.79M 12.57M
Total Equity 42.06M 8.48M 11.79M 12.57M
Total Liabilities & Stock Equity 59.40M 31.04M 31.97M 29.81M
Total Common Shares Outstanding 58.12M 35.37M 32.07M 31.78M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 1.97M 2.06M 2.13M
Basic Weighted Shares Outstanding 42.23M 32.58M 32.10M 30.46M
Diluted Weighted Shares Outstanding 42.23M 32.58M 32.10M 30.46M
Number of Employees 210 220 219 184
Number of Part-Time Employees 0 0 0 0

Analysts Ratings for BIOL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BIOL Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs